KRAS and colorectal carcinoma: Simvastatin and fluvastatin have demonstrated efficacy as adjuvants to oxaliplatin in KRAS-mutated CRC [303], while regorafenib and rosuvastatin combination therapy has shown synergistic effects both in vitro and in vivo [304].